Short Interest in Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) Grows By 15.7%

Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) was the recipient of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 731,000 shares, a growth of 15.7% from the January 15th total of 631,800 shares. Based on an average daily volume of 1,930,000 shares, the short-interest ratio is currently 0.4 days.

Petros Pharmaceuticals Price Performance

NASDAQ:PTPI traded up $0.05 on Monday, reaching $0.29. The stock had a trading volume of 107,200,541 shares, compared to its average volume of 383,633. Petros Pharmaceuticals has a 1-year low of $0.22 and a 1-year high of $1.76. The stock has a fifty day moving average price of $0.32 and a 200-day moving average price of $0.33. The company has a quick ratio of 0.74, a current ratio of 0.85 and a debt-to-equity ratio of 1.58. The company has a market capitalization of $2.94 million, a P/E ratio of -0.06 and a beta of 1.84.

About Petros Pharmaceuticals

Petros Pharmaceuticals, Inc, a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED).